Lumen Bioscience, a clinical-stage biopharmaceutical company developing products to treat and prevent highly prevalent diseases,…
dcorriganAugust 13, 2021
Integrative Oncogene-Dependency Mapping Identifies RIT1 Vulnerabilities and Synergies in Lung Cancer
CRISPR-based cancer dependency maps are accelerating advances in cancer precision medicine, but adequate functional maps…
dcorriganAugust 12, 2021
Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (Nasdaq: ADPT),…
dcorriganAugust 12, 2021
Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares…
dcorriganAugust 11, 2021
Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the company has…
dcorriganAugust 11, 2021
Targeted therapies have transformed outcomes for lung cancer patients. After reduced smoking rates, drugs that…
dcorriganAugust 11, 2021
Seagen Inc., a world leader and pioneer in antibody-drug conjugate (ADC) therapies, and RemeGen Co.,…
dcorriganAugust 10, 2021
Sonoma Biotherapeutics, a life sciences company developing treatments for autoimmune diseases, announced this week it raised $265…
dcorriganAugust 10, 2021
3’3’-cyclic di-adenosine monophosphate (c-di-AMP) is an important nucleotide second messenger found throughout the bacterial domain…
dcorriganAugust 10, 2021
